Trump’s IVF executive order doesn’t achieve much — yet

The latest stories trending on MedCity News.

Editor's Pick

Top Story Trump's IVF Executive Order Doesn't Actually Achieve Much — Yet President Donald Trump recently announced an executive order on IVF. But it doesn't actually do much yet. Rather, it's asking for a list of recommendations to protect IVF access. Sponsored Unlocking AI Potential: Navigating Data Risks and Rewards. Presented by symplr and MedCity News CEO BJ Schaknowski of symplr sits down with Katie Adams to discuss how healthcare consolidation drives the need for standardizing care delivery. This often involves simplifying the use of thousands of disparate applications. Learn more about how symplr is making healthcare less complex and more efficient. View It Now! Jasmi Shah, Managing Director at Cigna Ventures will be Speaking at INVEST 2025! Jasmi will be part of the panel: "Investor Perspective: What's Hot What's Not". In this panel you will hear from investment leaders from different healthcare industry sectors about the current investment climate. Learn about their strategic priorities and get advice on how startup founders can best succeed in fundraising. Register For INVEST Chicago Now & Save $345

Featured News

A Startup Provides Physician-led Virtual Visits for Women at Risk for Heart Disease Women's cardiovascular risk factors often don't get the attention they merit until it's too late. Systole Health CEO and Co-founder talked about how the company addresses this challenge. UnitedHealth Hit with 2 New Federal Probes in 1 Week This week, UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator's probe into its Medicare Advantage billing practices, and the second was a Congressman's investigation into a decline in care quality at Optum-owned clinics in New York. Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M Zevra Therapeutics received a priority review voucher for Miplyffa, the first FDA-approved treatment for the rare metabolic disorder Niemann Pick disease type C. Though Zevra has other drug candidates that could benefit from the voucher, the biotech is selling it to an undisclosed buyer. Whole Blood: The Next Frontier for EMS For decades, EMS has relied on blood component therapy, which was favored for its longer shelf life, efficiency, and lower risk of transfusion reactions. However, emerging data suggests that whole blood transfusion in the field could significantly improve survival rates, particularly in rural and remote areas where longer transport times pose additional risks. How an App Store Approach Fuels Innovation and Efficiency in Healthcare The app store approach in healthcare enables seamless integration of best-of-breed solutions with existing EMR systems, fostering innovation by accelerating the adoption of technologies like AI, telehealth, and remote monitoring.

Resources

sponsored New for 2025 EMR Software Pricing Guide Presented by MedCity News Make sure you're prepared for 2025 by knowing what to budget for EMR software. Our comprehensive pricing guide helps you compare the cost of top-rated EMR software solutions and offers insights too.   Gain Access Now

MedCity News • PO Box 901 • New York, NY unsubscribe